| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
5 companies
Casdin Partners Master Fund, L.P. is a Director, 10% Owner at STANDARD BIOTOOLS INC. with holdings across 5 companies. Recent SEC Form 4 filings include 17 buys and 2 sells.
Estimated insider holdings value: $240.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 358,220 | $1.24 | $443,032.57 | +0.2% | -2.4% | - | |
| Aug 11, 2025 | BLFS Biolife Solutions Inc | 10% Owner | Sell | 500,000 | $22.60 | $11,300,000.00 | -6.5% | +17.5% | - | |
| Jun 10, 2025 | BLFS Biolife Solutions Inc | 10% Owner | Sell | 1,000,000 | $23.80 | $23,800,000.00 | -11.5% | +9.7% | - | |
| Feb 28, 2025 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 4,820,959 | $1.07 | $5,134,321.34 | +8.9% | -0.5% | +7.0% | |
| Aug 27, 2024 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 250,000 | $2.19 | $546,750.00 | +0.5% | -25.7% | -41.3% | |
| Aug 26, 2024 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 750,000 | $2.06 | $1,546,237.01 | +0.5% | -25.3% | -40.6% | |
| Aug 21, 2024 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 1,250,000 | $1.88 | $2,351,875.00 | +0.8% | -22.2% | -38.1% | |
| Aug 14, 2024 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 1,200,000 | $1.59 | $1,913,520.00 | +2.4% | +32.3% | -21.3% | |
| Aug 13, 2024 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 1,575,408 | $1.62 | $2,559,641.38 | +1.1% | +36.8% | -19.6% | |
| Aug 8, 2024 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 1,069,562 | $1.61 | $1,718,800.82 | +1.1% | +35.3% | -21.9% |